Andrew Weng

Dr. Weng received his MD and PhD from the University of Chicago. Dr. Weng is now both a Distinguished Scientist at the Terry Fox Laboratory and a Clinical Hematopathologist at the BC Cancer Agency, and also a holds a Professor position in the Department of Pathology and Laboratory Medicine at the University of British Columbia. Dr. Weng is the Directors of both the Clinical Flow Cytometry Laboratory and Research Flow Cytometry Core Facility, and Medical Director of the Stem Cell Assay Clinical Lab at BC Cancer. His research program focuses on the pathogenesis of lymphoid malignancy specifically exploring the role of NOTCH1, an oncogenes/tumor suppressor gene, and the use of state-of-the-art mass cytometry (CyTOF) to obtain highly resolved phenotypic maps of heterogeneous cell populations present in leukemia patient samples.